Rising Incidence Of Infectious Diseases Fuels Growth In Molecular Diagnostic Devices Market Driving Market Acceleration in the Molecular Diagnostics Devices And Equipment Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Molecular Diagnostics Devices And Equipment Market Size By 2025?
In recent times, the molecular diagnostics devices and equipment market has seen significant expansion. The market is set to rise from $24.4 billion in 2024 to $27.23 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.6%. The notable growth during the historical period is a result of increased funding, growth in healthcare expenditure, economic evolution in emerging markets, fast-paced technological innovations, the appearance of new pathogenic infestations, and the accelerating growth of the elderly population.

How Big Is the Molecular Diagnostics Devices And Equipment Market Size Expected to Grow by 2029?
In the coming years, the molecular diagnostics devices and equipment market is poised for accelerated growth. It is projected to expand to a value of $42.59 billion in 2029 with a compound annual growth rate (CAGR) of 11.8%. This growth during the forecast period can be ascribed to the quick escalation of multiple bacterial and viral epidemics, an expanding older population, better access to healthcare, a rising number of chronic diseases and the mounting request for molecular diagnostic devices due to the COVID-19 pandemic. Key trends for the forecast period involve automation within molecular diagnostics, the application of artificial intelligence, a surge in demand for molecular diagnostic devices for researching rare diseases, the proliferating use of big data, next generation sequencing adopted for newborn screening, and point-of-care molecular diagnostics (POC mdx).

View the full report here:
https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Which Key Market Drivers Powering Molecular Diagnostics Devices And Equipment Market Expansion and Growth?
The growth of the molecular diagnostic devices and equipment market is projected to be spurred by the increasing instances of infectious diseases. These diseases are triggered by harmful microorganisms like bacteria, viruses, fungi, or parasites that can spread from one person to another or from animals to humans. Several factors, such as antimicrobial resistance, globalization and travel, urbanization, socioeconomic disparities, and an aging population, are the causes of this growing prevalence. Molecular diagnostic devices and equipment play a crucial role in detecting and managing these infectious diseases. For example, the UK's Office for National Statistics reported in March 2023 that the UK witnessed 619 deaths due to COVID-19 in the week ending 17 March 2023, a rise from 605 deaths the previous week. In this week, COVID-19-related deaths constituted 4.5% of all deaths in the UK, a minor decline from 4.6% the previous week. Thus, the increasing prevalence of infectious diseases is fuelling the expansion of the molecular diagnostic devices and equipment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp

Which Emerging Trends Are Transforming the Molecular Diagnostics Devices And Equipment Market in 2025?
Major entities in the molecular diagnostic market are prioritizing the development of automated tools for devices and equipment used in molecular diagnostics. By automating the procedure, both productivity and consistency of the overall diagnostic procedure can be boosted. Shifting the diagnostic process to digital means results in dependable and efficient outcomes, beyond what multiple experts doing manual testing can offer. Key entities in the sector are applying nanotechnology-based Oral Fluid Nano Sensor Test (OFNASET). This test utilizes a nanosensor based on microfluidics for detecting oral cancer biomarkers found in saliva. To keep up with the demand for automation and precision, Roche developed cobas connection modules (CCM), enhancing scalability and sample-flow effectiveness by allowing automatic transit between various systems and tools, culminating in a completely automated process.

What Are the Emerging Segments in the Molecular Diagnostics Devices And Equipment Market?
The molecular diagnostics devices and equipment market covered in this report is segmented -

1) By Product: Instruments, Reagents And Consumables, Software
2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies
3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications
4) By End User: Diagnostic laboratories, Hospitals, Other End Users

Subsegments:
1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays
2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials
3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2595&type=smp

Who Are the Global Leaders in the Molecular Diagnostics Devices And Equipment Market?
Major companies operating in the molecular diagnostics devices and equipment market include F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di'an Diagnostics Technology Co. Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, BGI-Shenzhen, OriGene Technologies, Bayer AG, Johnson & Johnson, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, Interlabservis, GeneMe, TestLine, Clinical Diagnostics s.r.o, Hologic Inc., Illumina Inc., Novartis AG, Cepheid Inc., Admera Health, Agilent technologies Inc., AutoGenomics, Bio-Red Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd.

Which are the Top Profitable Regional Markets for the Molecular Diagnostics Devices And Equipment Industry?
Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2024. Western Europe was the second largest market in molecular diagnostics devices (or) equipment market. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2595

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.